nCino, Inc.
12.11.2026 22:05:00 CET | Globenewswire | Press release
nCino Announces Timing of its Third Quarter Fiscal Year 2027 Financial Results Conference Call
nCino Announces Timing of its Third Quarter Fiscal Year 2027 Financial Results Conference Call
WILMINGTON, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, will report financial results for its third quarter ended October 31, 2026, after the market close on Tuesday, December 1, 2026. nCino will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results.
Event: nCino’s Third Quarter Fiscal Year 2027 Financial Results Conference Call
Date and Time: Tuesday, December 1, 2026 at 4:30 p.m. ET
Webcast Link: https://investor.ncino.com/
Replay: A webcast replay will be available on nCino’s Investor Relations website following the call.
About nCino
nCino (NASDAQ: NCNO) is the platform for agentic AI banking. With over 2,700 customers worldwide - including community banks, credit unions, independent mortgage banks, and the largest financial entities globally - nCino offers a trusted, agentic platform purpose-built for financial services and regulated industries. By deploying AI agents alongside human teams, nCino’s dual workforce enables institutions to eliminate inefficiencies, sharpen decision-making and deliver better outcomes for the customers they serve. For more information, visit www.ncino.com.
INVESTOR CONTACT
investor@ncino.com
MEDIA CONTACT
press@ncino.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
NAED Energy Holding Inc12.11.2026 22:42:40 CET | Press release
NAED Energy Holding Inc. Details the Rating of Its PV-1 Tandem Cell Line: 16,000 Wafers per Hour per Line, 4.6 GW from Six Lines
Standard Lithium12.11.2026 22:30:00 CET | Press release
Standard Lithium Reports Third Quarter 2026 Results
ProMIS Neurosciences Inc.12.11.2026 22:05:00 CET | Press release
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing
Cyclarity Therapeutics12.11.2026 20:34:38 CET | Press release
Cyclarity Therapeutics Receives FDA Investigational New Drug Clearance for UDP-003 to expand Atherosclerosis Clinical Development Program into the United States
Genmab A/S12.11.2026 20:09:02 CET | Press release
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom